{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:40:27Z","timestamp":1793572827642,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37097","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:59:46Z","timestamp":1724813986000},"page":"e37097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination"],"prefix":"10.1016","volume":"10","author":[{"given":"Sara","family":"Delghandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Raoufinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shahtahmasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Gouklani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-1612","authenticated-orcid":false,"given":"Aida","family":"Gholoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.dld.2013.01.022","article-title":"Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy","volume":"45","author":"Saitta","year":"2013","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gutjnl-2018-316490","article-title":"Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose","volume":"68","author":"Candotti","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib4","first-page":"1","article-title":"Association between serum levels of anti-heat shock protein 27 antibody and liver cell injury in chronic hepatitis B","author":"Yousefli","year":"2023","journal-title":"Indian J. Clin. Biochem."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37097_bib5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","article-title":"Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors","volume":"57","author":"Huang","year":"2012","journal-title":"Journal of hepatology"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37097_bib7","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/jmv.24859","article-title":"Impact of \u201ca\u201d determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B","volume":"89","author":"Huang","year":"2017","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.21529","article-title":"Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma","volume":"45","author":"Pollicino","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib9","series-title":"Seminars in Liver Disease","article-title":"The molecular virology of hepatitis B virus","year":"2013"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e37097_bib10","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3748\/wjg.v24.i14.1507","article-title":"Hepatitis B virus pre-S\/S variants in liver diseases","volume":"24","author":"Chen","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jmv.24936","article-title":"Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S\u2010gene mutants isolated from individuals with occult HBV infection","volume":"90","author":"Zhang","year":"2018","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/22221751.2019.1663130","article-title":"Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerg. Microb. Infect."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37097_bib13","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbagrm.2017.02.007","article-title":"Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription","volume":"1860","author":"Deng","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41598-020-57637-z","article-title":"HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA","volume":"10","author":"Chong","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/almed-2022-0065","article-title":"Control of occult hepatitis B virus infection","volume":"3","author":"Lalana Garc\u00e9s","year":"2022","journal-title":"Advances in Laboratory Medicine\/Avances en Medicina de Laboratorio"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22334","article-title":"Evaluation of the highly sensitive chemiluminescent enzyme immunoassay \u201cLumipulse HB sAg\u2010HQ\u201d for hepatitis B virus screening","volume":"32","author":"Deguchi","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib19","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JCM.00726-13","article-title":"Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance","volume":"51","author":"Shinkai","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e37097_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jviromet.2015.11.016","article-title":"The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen","volume":"228","author":"Yang","year":"2016","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.heliyon.2024.e37097_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12072-012-9354-7","article-title":"Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay","volume":"7","author":"Seto","year":"2013","journal-title":"Hepatology international"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib22","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1111\/hepr.12979","article-title":"Analysis of hepatitis B surface antigen (HBsAg) using high\u2010sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays","volume":"48","author":"Ozeki","year":"2018","journal-title":"Hepatol. Res."},{"issue":"60","key":"10.1016\/j.heliyon.2024.e37097_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2957\/kanzo.60.237","article-title":"Clinical usefulness of a newly developed high-sensitive hepatitis B surface antigen (HBsAg) assay for monitoring hepatitis B reactivation","volume":"60","author":"Oone","year":"2019","journal-title":"Kanzo"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/liv.13349","article-title":"Novel monitoring of hepatitis B reactivation based on ultra\u2010high sensitive hepatitis B surface antigen assay","volume":"37","author":"Shinkai","year":"2017","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000282074","article-title":"Occult hepatitis B virus infection: detection and significance","volume":"28","author":"Gerlich","year":"2010","journal-title":"Dig. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1423-0410.2012.01635.x","article-title":"Evaluation of two, commercial, multi\u2010dye, nucleic acid amplification technology tests, for HBV\/HCV\/HIV\u20101\/HIV\u20102 and B19V\/HAV, for screening blood and plasma for further manufacture","volume":"104","author":"Mueller","year":"2013","journal-title":"Vox Sang."},{"key":"10.1016\/j.heliyon.2024.e37097_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fmed.2018.00029","article-title":"Hepatitis B virus blood screening: need for reappraisal of blood safety measures?","volume":"5","author":"Candotti","year":"2018","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance","volume":"73","author":"Mak","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14218\/JCTH.2015.00020","article-title":"Asymptomatic hepadnaviral persistence and its consequences in the woodchuck model of occult hepatitis B virus infection","volume":"3","author":"Mulrooney-Cousins","year":"2015","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-22330-8_13","article-title":"Occult HBV infection","author":"Raimondo","year":"2016","journal-title":"Hepatitis B virus in human diseases"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","article-title":"Occult hepatitis B","volume":"2","author":"Torbenson","year":"2002","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib32","first-page":"19","article-title":"Comparison of PEG interferon loaded and non-loaded iron oxide nanoparticles on hepatitis C virus replication in cell culture system","volume":"11","author":"Ketabi","year":"2017","journal-title":"Iranian Journal of Virology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib33","first-page":"46","article-title":"Association of codon 72 of p53 gene polymorphism with chronic hepatitis C virus infection: a case control study","volume":"8","author":"Gerayli","year":"2016","journal-title":"J. Cell Mol. Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37097_bib34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/liv.14473","article-title":"Occult hepatitis B virus infection predicts non\u2010alcoholic steatohepatitis in severely obese individuals from Italy","volume":"40","author":"Raimondo","year":"2020","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib35","first-page":"480","article-title":"Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review","volume":"31","author":"Cholongitas","year":"2018","journal-title":"Ann. Gastroenterol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37097_bib36","article-title":"Global epidemiology of occult HBV infection","volume":"2","author":"Allain","year":"2017","journal-title":"Annals of Blood"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37097_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOH.0b013e32834bac10","article-title":"Challenges in hepatitis B detection among blood donors","volume":"18","author":"Allain","year":"2011","journal-title":"Curr. Opin. Hematol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib38","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"Journal of hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2009.01245.x","article-title":"Occult hepatitis B virus infection: a covert operation","volume":"17","author":"Hollinger","year":"2010","journal-title":"J. Viral Hepat."},{"issue":"8890","key":"10.1016\/j.heliyon.2024.e37097_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"Occult\" hepatitis B virus as source of infection in liver transplant recipients","volume":"343","author":"Chazouill\u00e8res","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from anti-hepatitis B core positive donors: a systematic review","volume":"52","author":"Cholongitas","year":"2010","journal-title":"Journal of hepatology"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/lt.22169","article-title":"Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis","volume":"16","author":"Cheung","year":"2010","journal-title":"Liver Transplant."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/lt.22312","article-title":"Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy","volume":"17","author":"Coffin","year":"2011","journal-title":"Liver Transplant."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/jhep.2003.50294","article-title":"HBV DNA persistence 10 years after liver transplantation despite successful anti\u2010HBS passive immunoprophylaxis","volume":"38","author":"Roche","year":"2003","journal-title":"Hepatology"},{"issue":"39","key":"10.1016\/j.heliyon.2024.e37097_bib45","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.3748\/wjg.v22.i39.8720","article-title":"Update on occult hepatitis B virus infection","volume":"22","author":"Makvandi","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37097_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jmv.21695","article-title":"Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin","volume":"82","author":"Levast","year":"2010","journal-title":"J. Med. Virol."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e37097_bib47","doi-asserted-by":"crossref","first-page":"15578","DOI":"10.1128\/JVI.79.24.15578-15581.2005","article-title":"Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection","volume":"79","author":"Rodriguez-Inigo","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000121363","article-title":"Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease: a prospective study","volume":"51","author":"Obika","year":"2008","journal-title":"Intervirology"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib49","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/jmv.20943","article-title":"Occult HBV infection may represent a major risk factor of non\u2010response to antiviral therapy of chronic hepatitis C","volume":"79","author":"Mrani","year":"2007","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.1057","article-title":"CV genotype and \u201csilent\u201d HBV coinfection: two main risk factors for a more severe liver disease","volume":"64","author":"Sagnelli","year":"2001","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jmv.10334","article-title":"Sequencing of human\u2010viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection","volume":"69","author":"Tamori","year":"2003","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2003.10.048","article-title":"Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection","volume":"126","author":"Pollicino","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37097_bib53","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/cncr.21702","article-title":"Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients","volume":"106","author":"Squadrito","year":"2006","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e37097_bib54","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-200210180-00024","article-title":"Lack of 'occult' hepatitis B virus infection in HIV-infected patients","volume":"16","author":"N\u00fa\u00f1ez","year":"2002","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.heliyon.2024.e37097_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2014.07.004","article-title":"Overt and occult hepatitis B virus infection in adult Sudanese HIV patients","volume":"29","author":"Mudawi","year":"2014","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37097_bib56","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/trf.12096","article-title":"Infectivity of blood products from donors with occult hepatitis B virus infection","volume":"53","author":"Allain","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib57","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.16873","article-title":"Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of Iran","volume":"8","author":"Hashemi","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1971.03190010023005","article-title":"Viral hepatitis, type B (MS-2 strain): studies on active immunization","volume":"217","author":"Krugman","year":"1971","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000441-197509000-00024","article-title":"Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees","volume":"270","author":"Purcell","year":"1975","journal-title":"Am. J. Med. Sci."},{"issue":"7974","key":"10.1016\/j.heliyon.2024.e37097_bib60","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(76)93023-3","article-title":"Immunisation against hepatitis B in man","volume":"307","author":"Maupas","year":"1976","journal-title":"Lancet"},{"issue":"5872","key":"10.1016\/j.heliyon.2024.e37097_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/298347a0","article-title":"Synthesis and assembly of hepatitis B virus surface antigen particles in yeast","volume":"298","author":"Valenzuela","year":"1982","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.heliyon.2024.e37097_bib62","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e37097_bib63","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.vaccine.2023.03.039","article-title":"First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic","volume":"41","author":"Dugovich","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1440-1746.2004.03153.x","article-title":"Legend of hepatitis B vaccination: the Taiwan experience","volume":"19","author":"Chan","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"23\u201324","key":"10.1016\/j.heliyon.2024.e37097_bib65","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/S0264-410X(99)00178-4","article-title":"Hepatitis B vaccination in infancy in the Gambia: protection against carriage at 9 years of age","volume":"17","author":"Viviani","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00430-004-0231-4","article-title":"Impact of the expanded program of immunization against hepatitis B infection in school children in Malaysia","volume":"194","author":"Ng","year":"2005","journal-title":"Medical microbiology and immunology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib67","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1542\/peds.2006-0724","article-title":"Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination","volume":"118","author":"Perz","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2009.01.002","article-title":"Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B","volume":"50","author":"Chen","year":"2009","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib69","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1590-8658(10)60685-8","article-title":"The worldwide impact of vaccination on the control and protection of viral hepatitis B","volume":"43","author":"Paladini","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.heliyon.2024.e37097_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.heliyon.2024.e37097_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","article-title":"Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives","volume":"204","author":"Gerlich","year":"2015","journal-title":"Medical microbiology and immunology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib72","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-015-2341-x","article-title":"Prevention of hepatitis B virus infection: from the past to the future","volume":"34","author":"Orlando","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib73","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0149-2918(01)80044-8","article-title":"Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines","volume":"23","author":"Coates","year":"2001","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e37097_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-90038-4_11","article-title":"Hepatitis B in the perinatal period","author":"Pierce-Williams","year":"2018","journal-title":"Neonatal Infections: Pathophysiology, Diagnosis, and Management"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib75","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/hep.27650","article-title":"Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population\u2010based study","volume":"61","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib76","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/trf.12902","article-title":"High prevalence of anti\u2010hepatitis B core antigen in hepatitis B virus\u2013vaccinated C hinese blood donors suggests insufficient protection but little threat to the blood supply","volume":"55","author":"Zheng","year":"2015","journal-title":"Transfusion"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e37097_bib77","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4254\/wjh.v7.i22.2418","article-title":"Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter national project","volume":"7","author":"Salama","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e37097_bib78","first-page":"247","article-title":"The prevalence and its meaning of anti-HBc alone 15 years subsequent to mass hepatitis B vaccination","volume":"13","author":"Chen","year":"2002","journal-title":"J. Intern. Med. Taiwan"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jhep.2005.06.016","article-title":"Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan","volume":"44","author":"Liu","year":"2006","journal-title":"Journal of hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jhep.2008.09.017","article-title":"Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan","volume":"50","author":"Mu","year":"2009","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37097_bib81","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.40492","article-title":"Serological patterns and molecular characterization of occult hepatitis B virus infection among blood donors","volume":"16","author":"Lin","year":"2016","journal-title":"Hepat. Mon."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37097_bib82","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.vaccine.2011.01.101","article-title":"Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers","volume":"29","author":"Chakvetadze","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib83","first-page":"831","article-title":"Response of health care workers with isolated antibody to hepatitis B core antigen to hepatitis B vaccine","volume":"42","author":"Chiarakul","year":"2011","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib84","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jvh.12102","article-title":"Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HB s A g\u2010positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial","volume":"20","author":"Pande","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070768","article-title":"Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib86","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.4161\/hv.29521","article-title":"Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination","volume":"10","author":"Elrashidy","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2024.e37097_bib87","first-page":"s63","article-title":"Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination","volume":"12","author":"Gessoni","year":"2014","journal-title":"Blood Transfusion"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib88","article-title":"Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigen","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib89","doi-asserted-by":"crossref","first-page":"134","DOI":"10.11599\/germs.2015.1081","article-title":"Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination","volume":"5","author":"Borzooy","year":"2015","journal-title":"Germs"},{"key":"10.1016\/j.heliyon.2024.e37097_bib90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s15010-015-0733-6","article-title":"Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis","volume":"43","author":"Foaud","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.heliyon.2024.e37097_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2014.11.032","article-title":"Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants","volume":"63","author":"Amponsah-Dacosta","year":"2015","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib92","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0956462415602419","article-title":"Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination","volume":"27","author":"Aghakhani","year":"2016","journal-title":"Int. J. STD AIDS"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37097_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139551","article-title":"Discovery of a novel mutation (X8Del) resulting in an 8-bp deletion in the hepatitis B virus X gene associated with occult infection in Korean vaccinated individuals","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib94","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s12879-016-1834-2","article-title":"Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"49","key":"10.1016\/j.heliyon.2024.e37097_bib95","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005625","article-title":"Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37097_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166317","article-title":"Occult HBV infection in immunized neonates born to HBsAg-positive mothers: a prospective and follow-up study","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37097_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184128","article-title":"Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: results of a prospective Italian study","volume":"12","author":"Morsica","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37097_bib98","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/ped.13352","article-title":"Occult hepatitis B virus infection in immunized children born to carrier mothers","volume":"59","author":"Yokoyama","year":"2017","journal-title":"Pediatr. Int. : official journal of the Japan Pediatric Society"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37097_bib99","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jmv.24861","article-title":"Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG\u2010administered infants born to HBsAg positive mothers","volume":"89","author":"Zhou","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2024.e37097_bib100","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00705-017-3365-6","article-title":"Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers","volume":"162","author":"Rodr\u00edguez","year":"2017","journal-title":"Arch. Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37097_bib101","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/jvh.12901","article-title":"Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide","volume":"25","author":"Tang","year":"2018","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.heliyon.2024.e37097_bib102","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12072-020-10055-9","article-title":"The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis","volume":"14","author":"Zhuge","year":"2020","journal-title":"Hepatology International"},{"key":"10.1016\/j.heliyon.2024.e37097_bib103","article-title":"Prevalence of overt and occult hepatitis B virus infection among an incarcerated population of Central-Western Brazil","volume":"241","author":"de Souza Marques","year":"2023","journal-title":"Acta Trop."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37097_bib104","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","article-title":"The e antigen and vertical transmission of hepatitis B surface antigen","volume":"105","author":"Beasley","year":"1977","journal-title":"American journal of epidemiology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib106","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/s41467-021-26475-6","article-title":"The impact of the timely birth dose vaccine on the global elimination of hepatitis B","volume":"12","author":"de Villiers","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37097_bib107","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S2468-1253(23)00071-7","article-title":"Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development","volume":"8","author":"Njuguna","year":"2023","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37097_bib108","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/trf.16559","article-title":"An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: implications for transfusion safety","volume":"61","author":"Vermeulen","year":"2021","journal-title":"Transfusion"},{"issue":"21\u201322","key":"10.1016\/j.heliyon.2024.e37097_bib109","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2004.01.046","article-title":"Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries","volume":"22","author":"Basuni","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2012.04.021","article-title":"High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG","volume":"57","author":"Shahmoradi","year":"2012","journal-title":"Journal of hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/liv.14252","article-title":"High prevalence of occult hepatitis B infection (OBI) among healthy children and their parents in Alborz province, Iran; Vertical OBI, myth or truth?","volume":"40","author":"Ghaziasadi","year":"2020","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib112","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jvh.12490","article-title":"Clearance of HBV DNA in immunized children born to HBsAg\u2010positive mothers, years after being diagnosed with occult HBV infection","volume":"23","author":"Sadeghi","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37097_bib113","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1586\/erv.11.151","article-title":"Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity","volume":"10","author":"Cassidy","year":"2011","journal-title":"Expet Rev. Vaccine"},{"issue":"37","key":"10.1016\/j.heliyon.2024.e37097_bib114","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1016\/j.vaccine.2010.06.106","article-title":"Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37097_bib115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e37097_bib116","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10096-015-2422-x","article-title":"Molecular mechanisms underlying HBsAg negativity in occult HBV infection","volume":"34","author":"Pond\u00e9","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37097_bib117","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.510300511","article-title":"Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan","volume":"30","author":"Hsu","year":"1999","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib118","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jmv.23513","article-title":"Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti\u2010HBc negative patient","volume":"85","author":"Feeney","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2024.e37097_bib119","series-title":"Global Hepatitis Report 2017","author":"Organization","year":"2017"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.heliyon.2024.e37097_bib121","series-title":"Do We Need Better Hepatitis B Vaccines?","first-page":"414","author":"Gerlich","year":"2017"},{"key":"10.1016\/j.heliyon.2024.e37097_bib122","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1386-6532(06)80004-1","article-title":"Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation","volume":"36","author":"Gerlich","year":"2006","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37097_bib123","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/vaccines12040439","article-title":"Hepatitis B vaccine: four decades on","volume":"12","author":"Mironova","year":"2024","journal-title":"Vaccines."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e37097_bib124","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2012.02.001","article-title":"Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine","volume":"30","author":"Sablan","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37097_bib125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37097_bib126","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2014.12.060","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus","volume":"33","author":"Janssen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e37097_bib127","volume":"vol. 2021","author":"Baker","year":"1900"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37097_bib128","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28652","article-title":"Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: a phase 3 randomized clinical trial","volume":"4","author":"Vesikari","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jac\/dku404","article-title":"Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+\/HBeAg\u2212 mothers: a systematic review and meta-analysis","volume":"70","author":"Machaira","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37097_bib130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/CVI.00539-12","article-title":"Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination","volume":"20","author":"Yao","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib131","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1086\/605698","article-title":"Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen","volume":"200","author":"Walz","year":"2009","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37097_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2012.28","article-title":"Emerging hepatitis B virus infection in vaccinated populations: a rising concern?","volume":"1","author":"Su","year":"2012","journal-title":"Emerg. Microb. Infect."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37097_bib133","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.vaccine.2010.11.044","article-title":"Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers","volume":"29","author":"Shim","year":"2011","journal-title":"Vaccine"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024131283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:23:19Z","timestamp":1790544199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024131283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":133,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024131283"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37097","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37097"}}